Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.30e-23	114	158	21	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.78e-22	124	158	21	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.48e-21	137	158	21	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L21 USP17L4 USP17L2 GPAA1 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.80e-19	192	158	22	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L21 USP17L4 USP17L2 GPAA1 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 ADAMTS16 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.03e-09	654	158	23	GO:0008233
GeneOntologyMolecularFunction	6-phosphofructokinase activity	PFKL PFKP	1.86e-04	3	158	2	GO:0003872
GeneOntologyMolecularFunction	fructose-6-phosphate binding	PFKL PFKP	6.13e-04	5	158	2	GO:0070095
GeneOntologyMolecularFunction	sodium channel activity	HCN3 GRIA2 HCN2 CACNA1G	7.60e-04	52	158	4	GO:0005272
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.79e-21	125	159	20	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.08e-19	144	159	20	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L21 SPRY2 USP17L4 TRIM25 USP17L2 USP17L12 USP17L1 DERL1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 NSMCE3 TRIP12 USP17L18 USP17L17 USP17L6P USP17L3 KLHL12 KLHL8 USP17L22 USP17L15 USP17L8 USP17L13	1.45e-08	1009	159	27	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L21 SPRY2 USP17L4 TRIM25 USP17L2 USP17L12 USP17L1 DERL1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 NSMCE3 TRIP12 USP17L18 USP17L17 USP17L6P USP17L3 KLHL12 KLHL8 USP17L22 USP17L15 USP17L8 USP17L13	5.26e-08	1074	159	27	GO:0043687
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L21 USP17L4 USP17L2 GPAA1 USP17L12 USP17L1 DERL1 USP17L20 USP17L11 ATL3 USP17L5 USP17L10 USP17L19 USP17L18 ACSL3 USP17L17 IRAG2 NAV3 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.01e-05	1327	162	24	GO:0042175
GeneOntologyCellularComponent	npBAF complex	ARID1A SMARCD1 PHF10	1.56e-04	14	162	3	GO:0071564
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L21 USP17L4 USP17L2 GPAA1 USP17L12 USP17L1 DERL1 USP17L20 USP17L11 ATL3 USP17L5 USP17L10 USP17L19 USP17L18 ACSL3 USP17L17 IRAG2 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.64e-04	1293	162	23	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L21 USP17L4 USP17L2 GPAA1 USP17L12 USP17L1 DERL1 USP17L20 USP17L11 ATL3 USP17L5 USP17L10 USP17L19 USP17L18 ACSL3 USP17L17 IRAG2 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.75e-04	1299	162	23	GO:0098827
GeneOntologyCellularComponent	6-phosphofructokinase complex	PFKL PFKP	1.78e-04	3	162	2	GO:0005945
GeneOntologyCellularComponent	HCN channel complex	HCN3 HCN2	3.54e-04	4	162	2	GO:0098855
GeneOntologyCellularComponent	axonal growth cone	APC TRAK1 PARD3 PALLD	4.04e-04	45	162	4	GO:0044295
GeneOntologyCellularComponent	centriolar satellite	CCDC14 PXK STAP1 AK5 KLHL12 PDZD2	4.92e-04	128	162	6	GO:0034451
Domain	HABP4_PAI-RBP1	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.23e-25	16	152	13	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.23e-25	16	152	13	IPR006861
Domain	UCH	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.88e-22	71	152	18	PF00443
Domain	USP_2	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.88e-22	71	152	18	PS00973
Domain	USP_3	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	2.49e-22	72	152	18	PS50235
Domain	USP_dom	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	2.49e-22	72	152	18	IPR028889
Domain	Peptidase_C19_UCH	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	2.49e-22	72	152	18	IPR001394
Domain	USP_CS	USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	2.16e-21	66	152	17	IPR018200
Domain	USP_1	USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	6.57e-21	70	152	17	PS00972
Domain	6-Pfructokinase_euk	PFKL PFKP	1.96e-04	3	152	2	IPR009161
Domain	PHOSPHOFRUCTOKINASE	PFKL PFKP	1.96e-04	3	152	2	PS00433
Domain	Phosphofructokinase_CS	PFKL PFKP	1.96e-04	3	152	2	IPR015912
Domain	PFK	PFKL PFKP	1.96e-04	3	152	2	PF00365
Domain	ATP_PFK	PFKL PFKP	1.96e-04	3	152	2	IPR022953
Domain	Phosphofructokinase_dom	PFKL PFKP	1.96e-04	3	152	2	IPR000023
Domain	VWF_type-D	SUSD2 MUC4 OTOG	2.74e-04	16	152	3	IPR001846
Domain	VWFD	SUSD2 MUC4 OTOG	2.74e-04	16	152	3	PS51233
Domain	VWD	SUSD2 MUC4 OTOG	2.74e-04	16	152	3	SM00216
Domain	VWD	SUSD2 MUC4 OTOG	2.74e-04	16	152	3	PF00094
Domain	Ion_trans_N	HCN3 HCN2	3.91e-04	4	152	2	IPR013621
Domain	AMOP	SUSD2 MUC4	3.91e-04	4	152	2	SM00723
Domain	Ion_trans_N	HCN3 HCN2	3.91e-04	4	152	2	PF08412
Domain	AMOP	SUSD2 MUC4	3.91e-04	4	152	2	PF03782
Domain	AMOP_dom	SUSD2 MUC4	3.91e-04	4	152	2	IPR005533
Domain	AMOP	SUSD2 MUC4	3.91e-04	4	152	2	PS50856
Domain	NUT	NUTM2G NUTM2F	6.47e-04	5	152	2	IPR024310
Domain	NUT_N	NUTM2G NUTM2F	6.47e-04	5	152	2	IPR024309
Domain	NUT	NUTM2G NUTM2F	6.47e-04	5	152	2	PF12881
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.77e-26	45	119	18	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.96e-14	191	119	18	MM15289
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 RANBP9 USP17L5 USP17L10 USP17L19 USP17L18 PTPN7 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 VCL USP17L8 USP17L13	2.13e-13	318	119	21	MM15278
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.73e-13	221	119	18	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 APC USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.33e-13	262	119	19	MM15286
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 TRIM25 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 APC USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.68e-13	299	119	20	M27574
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 SATB2 USP17L4 USP17L2 GPAA1 USP17L12 USP17L1 DERL1 USP17L20 USP17L11 APC USP17L5 USP17L10 USP17L19 NSMCE3 USP17L18 USP17L17 ADAMTS16 USP17L6P USP17L3 CHRDL1 FBXO27 USP17L22 MUC4 USP17L15 USP17L8 USP17L13	2.78e-05	1389	119	27	MM15307
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 SATB2 USP17L4 TRIM25 USP17L2 GPAA1 USP17L12 USP17L1 DERL1 USP17L20 USP17L11 USP17L24 APC USP17L5 USP17L10 USP17L19 NSMCE3 USP17L18 USP17L17 ADAMTS16 USP17L3 CHRDL1 FBXO27 USP17L22 MUC4 USP17L15 USP17L8 USP17L13	2.93e-05	1475	119	28	M19806
Pathway	REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION	SP1 ILF3 ZEB2	6.74e-05	10	119	3	M48016
Pathway	REACTOME_REGULATION_OF_CDH11_EXPRESSION_AND_FUNCTION	SP1 ILF3 ZEB2	1.22e-04	12	119	3	MM17071
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.28e-40	21	162	18	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.28e-40	21	162	18	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.28e-40	21	162	18	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.28e-40	21	162	18	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.28e-40	21	162	18	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.28e-40	21	162	18	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.89e-39	22	162	18	9154835
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 CDC25C USP17L15 USP17L8 USP17L13	3.20e-38	29	162	19	32527007
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.28e-38	24	162	18	8995226
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 CDC25C USP17L15 USP17L8 USP17L13	1.02e-37	37	162	20	20228808
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.88e-37	25	162	18	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.08e-37	26	162	18	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.29e-36	33	162	19	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.91e-36	34	162	19	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.34e-36	35	162	19	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.34e-36	35	162	19	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.34e-35	36	162	19	20147298
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.39e-30	50	162	18	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	4.95e-15	10	162	7	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	3.24e-14	12	162	7	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.39e-13	14	162	7	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	2.01e-12	19	162	7	28067227
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 ZNF521 USP17L5 USP17L10 USP17L19 USP17L18 PTPN7 USP17L17 TNFRSF8 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.87e-12	674	162	21	37196079
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SP1 PPAN HIVEP1 ILF3 TCF20 NUMA1 TFIP11 PHF8 PFKP NSMCE3 TRIP12 ACSL3 MGMT CHTF18 TAOK1 MICAL3 EIF3G PARD3 PHF10	4.30e-09	774	162	19	15302935
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L4 USP17L2 USP17L1 USP43 USP17L6P USP17L3 USP17L15 USP17L8	4.49e-09	81	162	8	12838346
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9L SATB2 HIVEP1 TCF20 ZNF521 DNPH1 ARID1A UBN2 ZEB2 ZNF608 SMARCD1 TADA2A PHF10	1.21e-08	351	162	13	38297188
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 PPAN USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	9.42e-08	119	162	8	28625976
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHANK1 CASC3 ILF3 TCF20 HCN3 NUMA1 RANBP9 NSD1 APC GRIA2 ARMCX4 HCN2 UBN2 ZEB2 ITIH4 ALYREF BAIAP2 PARD3 ARHGAP21	1.35e-07	963	162	19	28671696
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	3.95e-07	4	162	3	22984479
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 CASC3 HIVEP1 TCF20 USP43 APC PFKP TRIP12 MEX3C TRAK1 SH3BP4 BAIAP2 PARD3 CDC25C PALLD ARHGAP21 OTOG	6.36e-07	861	162	17	36931259
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	RALGAPA1 EPPK1 APC GRIA2 PFKL ATP9A HCN2 ACSL3 BAIAP2 PARD3 ARHGAP21 VCL	9.28e-07	430	162	12	32581705
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L4 USP17L1 TG USP17L3 USP17L8	3.00e-06	48	162	5	16421571
Pubmed	A human MAP kinase interactome.	SHANK1 CCDC14 SP1 HIVEP1 TCF20 RANBP9 APC SH3BP4 IRAG2 NAV3 BAIAP2 ARHGAP33	3.28e-06	486	162	12	20936779
Pubmed	Human transcription factor protein interaction networks.	BCL9L SP1 SATB2 PPAN HIVEP1 TCF20 NUMA1 ZNF521 TFIP11 PHF8 PFKP ARID1A UBN2 ZEB2 ZNF608 GLI2 SMARCD1 TADA2A EIF3G PHF10 VCL	3.37e-06	1429	162	21	35140242
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	SP1 PPAN ILF3 NUMA1 APC PFKP TRIP12 STAP1 SH3BP4 TAOK1 CDC25C PALLD	4.66e-06	503	162	12	16964243
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MPO ILF3 TRIM25 TCF20 NUMA1 RANBP9 ATL3 TFIP11 PFKL PHF8 PFKP ARID1A TRIP12 ACSL3 CHTF18 SLTM ALYREF PARD3 PALLD VCL	5.39e-06	1353	162	20	29467282
Pubmed	An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency.	NUMA1 ARID1A SMARCD1 PHF10	9.84e-06	29	162	4	19279220
Pubmed	Medical sequencing of candidate genes for nonsyndromic cleft lip and palate.	SPRY2 SATB2 GLI2	1.16e-05	10	162	3	16327884
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ATL3 APC TFIP11 PFKL SH3BP4 EFEMP1 CHTF18 AACS SLTM CHPF2 MICAL3 PALLD ARHGAP21	1.23e-05	650	162	13	38777146
Pubmed	Functional selectivity of recombinant mammalian SWI/SNF subunits.	SP1 ARID1A SMARCD1	1.59e-05	11	162	3	11018012
Pubmed	Hyperpolarization-activated cyclic nucleotide-modulated 'HCN' channels confer regular and faster rhythmicity to beating mouse embryonic stem cells.	HCN3 HCN2	2.16e-05	2	162	2	18033814
Pubmed	Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.	ZEB2 PDZD2	2.16e-05	2	162	2	23184150
Pubmed	Modulation of Ca(v)3.1 T-type Ca2+ channels by the ran binding protein RanBPM.	RANBP9 CACNA1G	2.16e-05	2	162	2	18801335
Pubmed	Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.	SP1 CACNA1G	2.16e-05	2	162	2	23868804
Pubmed	The association of methylation in the promoter of APC and MGMT and the prognosis of Taiwanese CRC patients.	APC MGMT	2.16e-05	2	162	2	19309276
Pubmed	Identification of the binding site for the Lutheran blood group glycoprotein on laminin alpha 5 through expression of chimeric laminin chains in vivo.	LAMA5 BCAM	2.16e-05	2	162	2	12244066
Pubmed	Transcriptional regulation of acetoacetyl-CoA synthetase by Sp1 in neuroblastoma cells.	SP1 AACS	2.16e-05	2	162	2	29137983
Pubmed	Laminin alpha 5 mediates ectopic adhesion of hepatocellular carcinoma through integrins and/or Lutheran/basal cell adhesion molecule.	LAMA5 BCAM	2.16e-05	2	162	2	18635166
Pubmed	Special AT-rich sequence-binding protein 2 suppresses invadopodia formation in HCT116 cells via palladin inhibition.	SATB2 PALLD	2.16e-05	2	162	2	25523619
Pubmed	The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.	APC LPAR2	2.16e-05	2	162	2	20724530
Pubmed	Localization of the human estrogen-responsive finger protein (EEP) gene (ZNF147) within a YAC contig containing the myeloperoxidase (MPO) gene.	MPO TRIM25	2.16e-05	2	162	2	8530055
Pubmed	ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription.	APC ARID1A	2.16e-05	2	162	2	33084574
Pubmed	Loss of polarity protein Par3 is mediated by transcription factor Sp1 in breast cancer.	SP1 PARD3	2.16e-05	2	162	2	34023783
Pubmed	The nuclear protein ALY binds to and modulates the activity of transcription factor E2F2.	E2F2 ALYREF	2.16e-05	2	162	2	23297349
Pubmed	Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer.	APC MUC4	2.16e-05	2	162	2	35255004
Pubmed	HCN3 ion channels: roles in sensory neuronal excitability and pain.	HCN3 HCN2	2.16e-05	2	162	2	31290157
Pubmed	An antibody to the lutheran glycoprotein (Lu) recognizing the LU4 blood type variant inhibits cell adhesion to laminin α5.	LAMA5 BCAM	2.16e-05	2	162	2	21858073
Pubmed	BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer.	LAMA5 BCAM	2.16e-05	2	162	2	27143691
Pubmed	The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer.	APC LPAR2	2.16e-05	2	162	2	19328876
Pubmed	Influence of myeloperoxidase on colon tumor occurrence in inflamed versus non-inflamed colons of Apc(Min/+) mice.	MPO APC	2.16e-05	2	162	2	26262998
Pubmed	JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.	SP1 TRIM25	2.16e-05	2	162	2	32576271
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	PPAN CCDC9B ILF3 NUMA1 RANBP9 APC TFIP11 PFKL PFKP ARID1A TRIP12 MEX3C SH3BP4 ZNF608 CHTF18 ALYREF PARD3 VCL	2.25e-05	1247	162	18	27684187
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TCF20 PHF8 ATP9A ZEB2 TRAK1 NAV3 CHPF2 MICAL3 ARHGAP21 PDZD2	2.30e-05	407	162	10	12693553
Pubmed	Separation and Quantification of Some Alkaloids from Fumaria parviflora by Capillary Isotachophoresis1.	ARID1A SMARCD1 PHF10	2.74e-05	13	162	3	17340523
Pubmed	A SMAD1/5-YAP signalling module drives radial glia self-amplification and growth of the developing cerebral cortex.	SATB2 APC ARID1A VCL	2.96e-05	38	162	4	32541003
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	NUMA1 APC PFKL SH3BP4 PARD3 CDC25C ARHGAP21	3.25e-05	190	162	7	15161933
Pubmed	PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes.	ARID1A SMARCD1 PHF10	4.33e-05	15	162	3	15985610
Pubmed	An essential switch in subunit composition of a chromatin remodeling complex during neural development.	ARID1A SMARCD1 PHF10	4.33e-05	15	162	3	17640523
Pubmed	Quantitative trait loci for steady-state platelet count in mice.	SLC46A1 OR1E3 ALYREF	4.33e-05	15	162	3	15520881
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	FAM234B STARD8 ZNF652 NSD1 APC TFIP11 PFKL UBN2 TRIP12 SLTM TAOK1 HMGXB3 LPAR2 PARD3 PCDH18 ARHGAP21	5.06e-05	1084	162	16	11544199
Pubmed	A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum.	SHANK1 NUMA1 GRIA2 CACNA1G	5.32e-05	44	162	4	32492419
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TCF20 NUMA1 NSD1 TFIP11 PHF8 PHAX ARID1A UBN2 PARD3 PALLD VCL	5.75e-05	549	162	11	38280479
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	CASC3 PPAN ILF3 NUMA1 PHAX USP17L18 ACSL3 CHTF18 SLTM ALYREF EIF3G PALLD	6.05e-05	653	162	12	33742100
Pubmed	The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.	ARID1A SMARCD1 PHF10	6.43e-05	17	162	3	11078522
Pubmed	Killer-cell immunoglobulin-like receptors and falciparum malaria in southwest Nigeria.	KIR2DS3 KIR2DS5	6.45e-05	3	162	2	24929143
Pubmed	MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer.	USP17L2 MGMT	6.45e-05	3	162	2	30718431
Pubmed	Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.	PFKL PFKP	6.45e-05	3	162	2	7825568
Pubmed	The lutheran/basal cell adhesion molecule promotes tumor cell migration by modulating integrin-mediated cell attachment to laminin-511 protein.	LAMA5 BCAM	6.45e-05	3	162	2	24036115
Pubmed	Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging.	LAMA5 BCAM	6.45e-05	3	162	2	29344581
Pubmed	Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins.	APC MGMT	6.45e-05	3	162	2	19029948
Pubmed	Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.	PFKL PFKP	6.45e-05	3	162	2	6444721
Pubmed	A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.	KIR2DS3 KIR2DS5	6.45e-05	3	162	2	8765026
Pubmed	Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction.	SP1 E2F2	6.45e-05	3	162	2	8657142
Pubmed	Transcriptional regulation of the human acetoacetyl-CoA synthetase gene by PPARgamma.	SP1 AACS	6.45e-05	3	162	2	20102333
Pubmed	Genomic organization, 5'flanking region and tissue-specific expression of mouse phosphofructokinase C gene.	PFKL PFKP	6.45e-05	3	162	2	11137296
Pubmed	Genotypes and phenotypes of congenital goitre and hypothyroidism caused by mutations in dual oxidase 2 genes.	DUOX2 TG	6.45e-05	3	162	2	24735383
Pubmed	Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation.	SP1 TNFRSF10B	6.45e-05	3	162	2	21167276
Pubmed	Crucial roles of MZF1 and Sp1 in the transcriptional regulation of the peptidylarginine deiminase type I gene (PADI1) in human keratinocytes.	SP1 PADI1	6.45e-05	3	162	2	17851584
Pubmed	LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to Inhibit DNMT3B-mediated methylation of the PHIP promoter.	SP1 TRIM25	6.45e-05	3	162	2	37742010
Interaction	SOX2 interactions	BCL9L SATB2 PPAN CCDC9B HIVEP1 ILF3 TCF20 NUMA1 RANBP9 NSD1 TFIP11 PFKL PFKP PHAX ARID1A UBN2 TRIP12 ZEB2 ITIH4 MEX3C ACSL3 ZNF608 SLTM NAV3 SMARCD1 ALYREF SNRPB PHF10 ARHGAP21	8.96e-07	1422	153	29	int:SOX2
Interaction	ERG interactions	SATB2 HIVEP1 ILF3 TRIM25 TCF20 NUMA1 ZNF521 ARID1A TRIP12 ZNF608 SMARCD1	1.12e-06	223	153	11	int:ERG
Interaction	HNF4A interactions	SP1 SATB2 HIVEP1 ZNF521 ARID1A UBN2 ZEB2 ZNF608 SMARCD1 TADA2A PHF10	8.43e-06	275	153	11	int:HNF4A
Interaction	SP7 interactions	BCL9L SATB2 HIVEP1 TCF20 TFIP11 PFKP ARID1A ZEB2 ZNF608 SMARCD1 PHF10	2.15e-05	304	153	11	int:SP7
Interaction	FEV interactions	SATB2 HIVEP1 TCF20 ZNF521 ARID1A UBN2 ZEB2 ZNF608 PHF10	2.55e-05	203	153	9	int:FEV
Interaction	TBXT interactions	SATB2 HIVEP1 TCF20 ARID1A ZEB2 ZNF608 SMARCD1	2.96e-05	116	153	7	int:TBXT
Interaction	EGR2 interactions	BCL9L HIVEP1 ZNF521 ARID1A UBN2 ZEB2 ZNF608 PHF10	4.97e-05	171	153	8	int:EGR2
Interaction	GSC interactions	BCL9L SATB2 HIVEP1 ZNF521 ZEB2 ZNF608	5.28e-05	87	153	6	int:GSC
Interaction	TLX1 interactions	SATB2 HIVEP1 TCF20 ARID1A UBN2 ZEB2 ZNF608 SMARCD1	5.85e-05	175	153	8	int:TLX1
Interaction	TEAD1 interactions	SATB2 HIVEP1 TRIM25 ARID1A ZEB2 ZNF608 SMARCD1 PHF10	6.09e-05	176	153	8	int:TEAD1
Interaction	NFIX interactions	SATB2 HIVEP1 TRIM25 ZNF521 ARID1A ZEB2 ZNF608 SMARCD1 VCL	6.10e-05	227	153	9	int:NFIX
Interaction	KLF3 interactions	SATB2 HIVEP1 TRIM25 DNPH1 ARID1A UBN2 ZEB2 ZNF608 TADA2A	6.31e-05	228	153	9	int:KLF3
Interaction	SOX10 interactions	SP1 HIVEP1 ARID1A ZNF608 SMARCD1 PHF10	7.23e-05	92	153	6	int:SOX10
Interaction	SOX17 interactions	SATB2 ILF3 TCF20 ARID1A SMARCD1 PHF10	8.65e-05	95	153	6	int:SOX17
Cytoband	4p16.1	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.74e-22	79	162	15	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	3.34e-15	222	162	15	chr4p16
Cytoband	8p23.1	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	2.28e-04	154	162	5	8p23.1
Cytoband	1p36	E2F2 NPHP4 TNFRSF8	6.24e-04	47	162	3	1p36
GeneFamily	PDZ domain containing	SHANK1 PARD3 ARHGAP21 CARD14 PDZD2	1.07e-03	152	92	5	1220
GeneFamily	Cyclic nucleotide gated channels	HCN3 HCN2	1.12e-03	10	92	2	250
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 RASIP1 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.57e-25	86	159	19	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	8.03e-21	112	159	18	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 BAIAP2 USP17L22 USP17L15 USP17L8 USP17L13	2.45e-19	160	159	19	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 BAIAP2 USP17L22 USP17L15 PADI1 USP17L8 USP17L13	2.71e-09	647	159	20	MM981
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 NUMA1 ATL3 USP17L5 USP17L10 USP17L19 ARID1A STAP1 USP17L18 USP17L17 IRAG2 USP17L6P USP17L3 ALYREF USP17L22 USP17L15 USP17L8 USP17L13	3.38e-08	1072	159	24	MM1031
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 USP17L4 KRT12 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 ATL3 USP17L5 SLC46A1 USP17L10 USP17L19 TNFRSF10B USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 PHF10 USP17L15 USP17L8 USP17L13	9.97e-07	1198	159	23	MM1062
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 USP17L4 USP17L2 GPAA1 USP17L12 USP17L1 RHBG USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 BAIAP2 USP17L22 USP17L15 PADI1 USP17L8 USP17L13	5.21e-06	1226	159	22	MM979
Coexpression	GSE17721_LPS_VS_CPG_6H_BMDC_UP	VRK1 ILF3 STARD8 RHBG USP43 ATL3 SLC46A1 PFKP	3.17e-05	200	159	8	M3998
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)\|bone_marrow / Manually curated celltypes from each tissue	CCDC14 E2F2 ZNF608 KCNE1 FAM229A CHTF18 BFSP2 ARHGAP21	1.41e-07	173	151	8	67f0f0bf88eab69987b71d96b864ed2b14975adb
ToppCell	severe-unassigned\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MPO STARD8 SOWAHD E2F2 RASIP1 ARHGAP33 RAD54L	2.81e-07	128	151	7	bef9cf0078fa8498d63f0723f1fa4a3c92405e10
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SOWAHD SLC46A1 HCN2 KCNE1 CHTF18 LPAR2 CDC25C RAD54L	3.81e-07	197	151	8	d669d90c3f9e98b41bcbc49dbdc5698e0b42597c
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	ZNF521 FAM227B GLI2 ADAMTS16 NAV3 PARD3 PALLD	5.02e-06	197	151	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCDC14 CARMIL3 ZNF608 IRAG2 VRTN BCAM	2.36e-05	168	151	6	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CERKL SATB2 BATF3 BAIAP2 C6orf141 PDZD2	3.37e-05	179	151	6	9ba8693fba2175bca9ff9735cc04e657abeb9084
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 ZNF521 RASIP1 BAIAP2 C6orf141 EPHB1	3.81e-05	183	151	6	38a54216458ad57f356bb4ddf272e1af8036ddeb
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	E2F2 IRAG2 MICAL3 CDC25C BFSP2 RAD54L	4.05e-05	185	151	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 NSD1 APC RASIP1 ZNF608 BCAM	4.17e-05	186	151	6	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	10x5'-Lung-Lymphocytic_Invariant-Inducer-like-ILC3\|Lung / Manually curated celltypes from each tissue	SLC46A1 FAM227B SCART1 MICAL3 C6orf141 PDZD2	4.30e-05	187	151	6	0e7aa481effdd8c2fbdf8b65852821dec2d92cde
ToppCell	tumor_Lung-Endothelial_cells-Lymphatic_ECs\|tumor_Lung / Location, Cell class and cell subclass	ADCY4 ZNF521 RASIP1 EFEMP1 C6orf141 EPHB1	4.30e-05	187	151	6	87ecdc5f24aced95a37e653429f0fc493ff4aa3e
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	ADCY4 ZNF521 RASIP1 MICAL3 C6orf141 EPHB1	4.30e-05	187	151	6	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	ZNF521 EFEMP1 GLI2 ADAMTS16 NAV3 CHRDL1	4.70e-05	190	151	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-GMP\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MPO NBEAL1 DNPH1 PTPN7 CLEC11A C1QTNF4	5.27e-05	194	151	6	02b7911d07938f04f369a552dedc614930e4396e
ToppCell	ILEUM-non-inflamed-(6)_ILC-(6)_ILC1\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RALGAPA1 SPRY2 ZEB2 MEX3C IRAG2 EIF3G	5.58e-05	196	151	6	8a3a63129adfbe58558af91336f81d397c291ed0
ToppCell	ILEUM-inflamed-(6)_ILC-(6)_ILC1\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RALGAPA1 SPRY2 ZEB2 MEX3C IRAG2 EIF3G	5.58e-05	196	151	6	c1d84d2e4ecc83134c3c694bed3cf035bd2742af
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn\|World / Primary Cells by Cluster	SATB2 TRAK1 ZNF608 CHRDL1 ARHGAP21 EPHB1	5.58e-05	196	151	6	9401bd84798f0ea3e986e94135a9e1dc5643330f
ToppCell	mLN-B_cell-B_cell_cycling\|mLN / Region, Cell class and subclass	CASC3 TRIM25 MICAL3 BATF3 BFSP2 PALLD	5.74e-05	197	151	6	806dddcca85c82bd642008d930c8db16b613d88e
ToppCell	severe-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MPO E2F2 RASIP1 PTPN7 ARHGAP33 RAD54L	5.74e-05	197	151	6	70704b149b2820b8601d2495b7cd9cbe91eda262
ToppCell	distal-3-Endothelial-Lymphatic\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADCY4 ZNF521 RASIP1 EFEMP1 CHRDL1 C6orf141	5.74e-05	197	151	6	9ea0e2ed9c3f97591a06e70570640996580417d5
ToppCell	3'-Child09-12-SmallIntestine-Endothelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 STARD8 ZNF521 RASIP1 BCAM C6orf141	5.74e-05	197	151	6	86a02fd7b4762b3278e5e60b5483b5fc1206e597
ToppCell	mLN-(2)_B_cell-(24)_B_cell_cycling\|mLN / shred on region, Cell_type, and subtype	CASC3 TRIM25 MICAL3 BATF3 BFSP2 PALLD	5.74e-05	197	151	6	70fff2d6723f259e18e7a21d22dc46d71f0759ce
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF521 SH3BP4 EFEMP1 GLI2 CHRDL1 PARD3	5.91e-05	198	151	6	5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb
ToppCell	distal-1-Endothelial-Lymphatic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MPO ADCY4 RASIP1 EFEMP1 CHRDL1 C6orf141	5.91e-05	198	151	6	b6fea363463c8dd7e6780c085ece4900266a6286
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF521 SH3BP4 EFEMP1 GLI2 CHRDL1 PARD3	5.91e-05	198	151	6	ff6d9455ebfe965cc6f48197172c0ebd3bddde81
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF521 SH3BP4 EFEMP1 GLI2 CHRDL1 PARD3	5.91e-05	198	151	6	5375a2895cf995f0db4a61861093f01794707901
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADCY4 STARD8 ZNF521 RASIP1 CHRDL1 C6orf141	5.91e-05	198	151	6	b3a020522e064bb61949d38e442f24026e339364
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF521 SH3BP4 EFEMP1 GLI2 CHRDL1 PARD3	5.91e-05	198	151	6	35edf6d5bedc2181fbdd56f43e458bc39f4eca16
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADCY4 STARD8 ZNF521 RASIP1 CHRDL1 C6orf141	5.91e-05	198	151	6	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col6a1_Fezf2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SATB2 KRT12 SUSD2 VRTN BATF3	6.02e-05	122	151	5	e96aec5af0ed1d8f4cc99fde59dd6998bbc1acbd
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ILF3 TRIM25 VSIG4 ZEB2 NUTM2G PTPN7	6.07e-05	199	151	6	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ZEB2 CLEC11A CHRDL1 PCDH18 PALLD VCL	6.24e-05	200	151	6	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB2 CLEC11A CHRDL1 PCDH18 PALLD VCL	6.24e-05	200	151	6	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	ZEB2 CLEC11A CHRDL1 PCDH18 PALLD VCL	6.24e-05	200	151	6	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ZEB2 CLEC11A CHRDL1 PCDH18 PALLD VCL	6.24e-05	200	151	6	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	ZEB2 CLEC11A CHRDL1 IGSF9B PCDH18 PALLD	6.24e-05	200	151	6	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	ZEB2 CLEC11A CHRDL1 PCDH18 PALLD VCL	6.24e-05	200	151	6	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VRK1 E2F2 CHTF18 CDC25C ARHGAP33 RAD54L	6.24e-05	200	151	6	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	ZEB2 CLEC11A CHRDL1 PCDH18 PALLD VCL	6.24e-05	200	151	6	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	ZEB2 EFEMP1 CLEC11A PCDH18 VCL PDZD2	6.24e-05	200	151	6	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SUSD2 ADAMTS16 BCAM PCDH18 PADI1	1.04e-04	137	151	5	5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor\|bone_marrow / Manually curated celltypes from each tissue	MPO E2F2 CLEC11A CHTF18 RAD54L	1.41e-04	146	151	5	035393166f3ad5ab95602a8ae11b7d0ee4b1d691
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARMIL3 PFKP NAV3 CACNA1G CARD14	1.59e-04	150	151	5	909ccab92855f5f049dc29593aadab1ea973297b
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SATB2 CCDC9B ZNF521 ZEB2 KCNE1	1.75e-04	153	151	5	764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PFKP STAP1 KLHL8 C6orf141 MUC4	1.75e-04	153	151	5	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MPO DNPH1 TNFRSF8 NAV3 BFSP2	1.80e-04	154	151	5	b16f3139ce50e70a6a2377b1da7d7877b4000ea1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADCY4 ZNF521 RASIP1 NAV3 BATF3	1.86e-04	155	151	5	59035d792c26d870a8b097939e97fa47859ba68c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SOWAHD VSIG4 SH3BP4 PALLD ARHGAP21	1.91e-04	156	151	5	5b2781d38a83b4b0f8a53cf321ce5db3a07d0818
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SOWAHD VSIG4 SH3BP4 PALLD ARHGAP21	1.91e-04	156	151	5	e0aef6104be16b12304b8e30358f444c1660e92f
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 VSIG4 ITIH4 MICAL3 CACNA1G	2.15e-04	160	151	5	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 VSIG4 ITIH4 MICAL3 CACNA1G	2.15e-04	160	151	5	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 VSIG4 ITIH4 MICAL3 CACNA1G	2.22e-04	161	151	5	60f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	FAM234B CCDC9B VSIG4 TNFRSF8 BATF3	2.28e-04	162	151	5	2f19539c455d1e5d514725845234c7547020e6ad
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HCN3 SOWAHD UBN2 ITIH4	2.28e-04	88	151	4	1ca0e16981e88030987412e12838a9797b97b9c9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PPAN CARMIL3 TRAK1 BAIAP2 RAD54L	2.35e-04	163	151	5	ce07bc424ef99c547588b07f5c8b39ff0773ca9b
ToppCell	PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VRK1 PFKP CHTF18 BATF3 C6orf141	2.35e-04	163	151	5	7af3d3ae7e0de733a18d0486c7ffbb5a7ef7230a
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_C\|TCGA-Thymus / Sample_Type by Project: Shred V9	DERL1 CARMIL3 AACS IGSF9B MUC4	2.35e-04	163	151	5	2dac87d15051151ccf193760ddd8b82534c3f922
ToppCell	Frontal_cortex\|World / BrainAtlas - Mouse McCarroll V32	SATB2 KRT12 HIVEP1 ZEB2 CHRDL1	2.41e-04	164	151	5	e09291711abf8680e78170328313719092b0142f
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|356C / Donor, Lineage, Cell class and subclass (all cells)	STARD8 SOWAHD PFKP TG BATF3	2.48e-04	165	151	5	35a6de30438de364ccca948fc932da541a69ef89
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	MPO ZNF521 CHRDL1 PARD3 CDC25C	2.48e-04	165	151	5	7b992843bd8ef92a7a76b1d681fa84efde6f5bdd
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCDC14 EPPK1 IRAG2 VRTN FBXO27	2.48e-04	165	151	5	34fd00be2b28716c871ad9fb356de84a299a0c01
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	E2F2 STAP1 TG IRAG2 BFSP2	2.55e-04	166	151	5	fc2cf67311c86fda75b35fcd4768b6f6f14c59d0
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SP1 NUMA1 ARID1A TRAK1 ZNF608	2.55e-04	166	151	5	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	E2F2 STAP1 TG IRAG2 BFSP2	2.55e-04	166	151	5	33a6876d06e26176135a73a77c19e634ec53f7ce
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	ZNF521 CHRDL1 C1QTNF4 C6orf141 PALLD	2.62e-04	167	151	5	cb396f3edb9e8fdc316091e8e193dbba50e0be0c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RHBG ATP9A STAP1 SH3BP4 VCL	2.62e-04	167	151	5	edc5f04584b44f99ff9a62bbe0dab6fc044fb334
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHBG EFEMP1 FAM229A ADAMTS16 C6orf141	2.70e-04	168	151	5	100ab6d36592b61f4db9f8cb90c48afac016d679
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOWAHD PTPN7 KCNE1 IRAG2 BATF3	2.77e-04	169	151	5	630d921aa8fb5681d06a4e09b833855c374be484
ToppCell	Endothelial-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ADCY4 ZNF521 ZIC5 CHRDL1 EPHB1	2.77e-04	169	151	5	95c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOWAHD PTPN7 KCNE1 IRAG2 BATF3	2.77e-04	169	151	5	468284d4a3a0557aed04eadb1aba2317babc6904
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOWAHD PTPN7 KCNE1 IRAG2 BATF3	2.77e-04	169	151	5	6f765e142d127545e622fe24b5287cd6e9706ccc
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SH3BP4 ZNF608 BATF3 FBXO27 C6orf141	2.77e-04	169	151	5	e3410ccb3f85811c75694e286115803911169a2f
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SH3BP4 ZNF608 BATF3 FBXO27 C6orf141	2.77e-04	169	151	5	a4f610d07c3ba5537f4497f523669b914f7eddc1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RHBG SOWAHD USP43 PXK STAP1	2.85e-04	170	151	5	3229f2a02bfa075aa61118552d0407fc018ab3d1
ToppCell	metastatic_Brain-B_lymphocytes-Undetermined\|B_lymphocytes / Location, Cell class and cell subclass	SATB2 NSMCE3 HCN2 STAP1 KLHL8	2.93e-04	171	151	5	0d14bc9688c427ba2265984987dc3eea195b19eb
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPRY2 ZNF521 ZEB2 NAV3 SMARCD1	3.01e-04	172	151	5	b3c4adccc34bb9e4e78e40f4e2e23736c347cc75
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|Monocyte / Donor, Lineage, Cell class and subclass (all cells)	DERL1 SOWAHD PFKP TG BATF3	3.01e-04	172	151	5	9dca1542145d88559527db7e0f6ad150df59ca2d
ToppCell	facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPRY2 ZNF521 ZEB2 NAV3 SMARCD1	3.01e-04	172	151	5	2f1673fcb2356684d60871debb0f159aec553a1c
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF521 RASIP1 EFEMP1 CHRDL1 C6orf141	3.01e-04	172	151	5	1bad7b19724e1b53ace7e05644215334c9f43910
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ADCY4 LAMA5 RASIP1 TNFRSF8 BCAM	3.09e-04	173	151	5	ec88e871b49331fca59bc610a8ae58e2d5e76bc1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SATB2 USP43 ZNF521 METTL21C IRAG2	3.09e-04	173	151	5	8335b77f730ed43fc348a005566e73a103c6774b
ToppCell	droplet-Fat-Scat-21m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 SATB2 NBEAL1 RASIP1 PDZD2	3.09e-04	173	151	5	f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	ADCY4 LAMA5 RASIP1 TNFRSF8 BCAM	3.09e-04	173	151	5	22200fe74e33e2beae0eed289ca8476bbc0b1b2d
ToppCell	facs-Marrow-KLS-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT12 ATP9A TG NAV3 C1QTNF4	3.09e-04	173	151	5	295bfe1efa648173c2d5981025bc61c576baf53f
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors\|lymph-node_spleen / Manually curated celltypes from each tissue	MPO CLEC11A CHRDL1 C1QTNF4 CDC25C	3.17e-04	174	151	5	029394e107bf7ad58056d2216070aa2e964fff12
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	USP43 LAMA5 EFEMP1 SUSD2 BCAM	3.17e-04	174	151	5	2cd6638b361ca05ab83d09ce657194aed97873b7
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RALGAPA1 ADCY4 POM121L2 RASIP1 BCAM	3.17e-04	174	151	5	40bb87d219aafab0357ab0d797efd38085fc0312
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADCY4 ZNF521 DUOX2 RASIP1 EPHB1	3.25e-04	175	151	5	2e54961846c65b185d9bd6e305dd81205579d890
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PFKP STAP1 PTPN7 IRAG2 EPHB1	3.25e-04	175	151	5	fa53ea81ad943a2cd266114829135cbcbcf2f634
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHBG EFEMP1 FAM229A ADAMTS16 C6orf141	3.25e-04	175	151	5	6bb8fc2959583644f16b22e906af91af62a3a633
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cel\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHBG EFEMP1 FAM229A ADAMTS16 C6orf141	3.25e-04	175	151	5	8902c38067f025b094ca9c28c449c32a66eded1c
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADCY4 ZNF521 DUOX2 RASIP1 EPHB1	3.25e-04	175	151	5	efa6a05f7417d46141b6e635f258c126b7a03aa1
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADCY4 GOLM2 HCN2 RASIP1 ZNF608	3.34e-04	176	151	5	269326c2bf44a9003d95bc6dbc839f08f25737ca
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARMCX4 NAV3 CHRDL1 PARD3 VCL	3.34e-04	176	151	5	a8875b4ba4abf6625cdeb67bf544ce1573c59060
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	PPAN TRIM25 NSD1 SLC46A1 IGSF9B	3.34e-04	176	151	5	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	IIH-mDC1-\|IIH / Condition, Cell_class and T cell subcluster	LAMA5 ZNF608 BATF3 FBXO27 RAD54L	3.34e-04	176	151	5	bb80a3e595d071f6cc8b042984b8d9490e377eef
ToppCell	IIH-mDC1\|IIH / Condition, Cell_class and T cell subcluster	LAMA5 ZNF608 BATF3 FBXO27 RAD54L	3.34e-04	176	151	5	a75dc132a1061006fd1cb305bd314784fca07ea6
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	E2F2 ZEB2 KCNE1 TNFRSF8 RAD54L	3.43e-04	177	151	5	f28243b51be104cb3adcde63f03fc2206ed3121e
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	PPAN TRIM25 NSD1 SLC46A1 IGSF9B	3.43e-04	177	151	5	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC9B GRIA2 SLC46A1 ARMCX4 ITIH4	3.43e-04	177	151	5	8abdf1d970b2f15e17e185f3e612dd5065c88757
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.03e-32	46	154	19	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.06e-28	69	154	19	DOID:1682 (implicated_via_orthology)
Disease	Coffin-Siris syndrome (implicated_via_orthology)	ARID1A SMARCD1 PHF10	1.14e-05	9	154	3	DOID:1925 (implicated_via_orthology)
Disease	body surface area	RALGAPA1 SATB2 HIVEP1 NSD1 TRIP12 EFEMP1 MGMT ZNF608 GLI2 BAIAP2 FBXO27 PARD3	1.49e-04	643	154	12	EFO_0022196
Disease	glycogen storage disease (implicated_via_orthology)	PFKL PFKP	1.61e-04	4	154	2	DOID:2747 (implicated_via_orthology)
Disease	stem Cell Growth Factor-beta measurement	SHANK1 CLEC11A	2.68e-04	5	154	2	EFO_0802090
Disease	pancreatic cancer (is_implicated_in)	MPO APC MUC4 PALLD RAD54L	3.11e-04	112	154	5	DOID:1793 (is_implicated_in)
Disease	Thyroid Dyshormonogenesis 1	DUOX2 TG	4.00e-04	6	154	2	C1848805
Disease	response to iloperidone	CERKL PALLD	4.00e-04	6	154	2	GO_0036287
Disease	stem cell growth factor-alpha measurement	SHANK1 CLEC11A	5.59e-04	7	154	2	EFO_0020754
Disease	suberic acid measurement	VRK1 PDZD2	5.59e-04	7	154	2	EFO_0010534
Disease	Goiter	DUOX2 TG	5.59e-04	7	154	2	C0018021
Disease	Intellectual Disability	RALGAPA1 VRK1 TCF20 NSD1 APC GRIA2 SMARCD1 TAOK1 CACNA1G	5.94e-04	447	154	9	C3714756
Disease	body weight	RALGAPA1 CCDC9B HIVEP1 NBEAL1 ZNF521 POM121L2 TRIP12 MEX3C ACSL3 EFEMP1 CHRDL1 BAIAP2 FBXO27 NUTM2F PDZD2 EPHB1	9.49e-04	1261	154	16	EFO_0004338
Disease	primary bacterial infectious disease (implicated_via_orthology)	DUOX2 GLI2	9.51e-04	9	154	2	DOID:0050338 (implicated_via_orthology)
Disease	neuroblastoma (is_implicated_in)	NSD1 ARID1A	1.18e-03	10	154	2	DOID:769 (is_implicated_in)
Disease	WNT1-inducible-signaling pathway protein 1 measurement	SLC46A1 TG	1.18e-03	10	154	2	EFO_0008321
Disease	smoking behaviour measurement, waist-hip ratio	MGMT BCAM	1.44e-03	11	154	2	EFO_0004343, EFO_0005671
Disease	urgency urinary incontinence	ZNF521 ADAMTS16	1.73e-03	12	154	2	EFO_0006865
Disease	Pancreatic Neoplasm	APC TNFRSF10B EFEMP1 PALLD	1.90e-03	100	154	4	C0030297
Disease	Congenital Hypothyroidism	DUOX2 TG	2.03e-03	13	154	2	C0010308
Disease	hypothyroidism (implicated_via_orthology)	DUOX2 TG	2.03e-03	13	154	2	DOID:1459 (implicated_via_orthology)
Disease	Malignant neoplasm of pancreas	APC TNFRSF10B EFEMP1 PALLD	2.04e-03	102	154	4	C0346647
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	TCF20 ARID1A BCAM EPHB1	2.11e-03	103	154	4	EFO_0008595, EFO_0020944
Disease	congenital hypothyroidism (implicated_via_orthology)	DUOX2 TG	2.36e-03	14	154	2	DOID:0050328 (implicated_via_orthology)
Disease	central nervous system disease (implicated_via_orthology)	GRIA2 TAOK1	3.10e-03	16	154	2	DOID:331 (implicated_via_orthology)
Disease	Polyposis, Adenomatous Intestinal	APC ITIH4	3.10e-03	16	154	2	C2713442
Disease	Familial Intestinal Polyposis	APC ITIH4	3.10e-03	16	154	2	C2713443
Disease	prostate cancer (is_implicated_in)	APC ACSL3 CDC25C EPHB1	3.35e-03	117	154	4	DOID:10283 (is_implicated_in)
Disease	Adenomatous Polyposis Coli	APC ITIH4	3.50e-03	17	154	2	C0032580
Disease	schizophrenia, sex interaction measurement	SH3BP4 SLTM NAV3	3.84e-03	60	154	3	EFO_0008343, MONDO_0005090
Disease	Colorectal Carcinoma	SHANK1 MPO SATB2 CCDC9B STARD8 APC ARID1A ZEB2 EFEMP1 VRTN	3.91e-03	702	154	10	C0009402
Disease	pancreatic ductal carcinoma (is_marker_for)	MGMT MUC4 PALLD	4.02e-03	61	154	3	DOID:3587 (is_marker_for)
Disease	polychlorinated biphenyls measurement	SPRY2 ZNF521 PALLD	4.81e-03	65	154	3	EFO_0007042
Disease	maximal midexpiratory flow rate	IGSF11 MICAL3	4.83e-03	20	154	2	EFO_0004313

Protein segments in the cluster

Peptide	Gene	Start	Entry
TCQRRSSRAGPGKMQ	FAM227B	6	Q96M60
STAGRAPRGLDMSAQ	FAM229A	41	H3BQW9
SLRQGMRADPGVLAA	CHTF18	526	Q8WVB6
GASRRGESMQPNRRA	EIF3G	221	O75821
PQSGRVLSAMIRGAA	DNPH1	121	O43598
MLGRSDGTLNPNGVR	AACS	536	Q86V21
RPGARRAASQSAMLQ	C1QTNF4	111	Q9BXJ3
AEIMARLQAGQGSRP	ADCY4	241	Q8NFM4
MRGGENRPPARVQSS	CCDC180	1	Q9P1Z9
MSQGLPAAGSVLQRS	BATF3	1	Q9NR55
ASRTNAMSGLVRAPG	BFSP2	41	Q13515
RGPQNSNTRGMEEAS	CCDC14	731	Q49A88
ATVDARGNPNGMSRE	ARMCX4	256	Q5H9R4
NIMSPTLAGRNGVFS	ADAMTS16	456	Q8TE57
AGAAGSRMNFRPGVL	ITIH4	651	Q14624
GGQRNALQAISPATM	NBEAL1	226	Q6ZS30
GIGLSAQGVNMNRLP	RANBP9	231	Q96S59
ASLLNSLMERGQGRP	RASIP1	781	Q5U651
ANPANVSASKGRLMR	NSD1	1646	Q96L73
FPKSGGRQMARAVRN	PADI1	436	Q9ULC6
EGFMNQRGARVSSPI	RAD54L	256	Q92698
MVQAHGGRSRAQPLT	PTPN7	1	P35236
SSPTLERGQMGSRQS	PCDH18	781	Q9HCL0
LPGMSRSNSVGIQDA	ARID1A	1176	O14497
SQTNTARIDGLRPGM	EPHB1	486	P54762
VAQRSGNPVLMGFSS	MUC4	4496	Q99102
RQRGGCSNRSADPTM	SLC46A1	61	Q96NT5
NAPAQSIGIRRQGSM	MICAL3	736	Q7RTP6
LSSQSVIGRPRGMSA	KRT12	21	Q99456
AQGGASTRIMLPENG	LPAR2	326	Q9HBW0
GMQSSPLQGRAGAIQ	GPAA1	206	O43292
NGGQSRRSFLRNVMP	AK5	71	Q9Y6K8
AGNPKAARAVGGAMR	MGMT	121	P16455
APGTRQENGMATRLD	CARMIL3	996	Q8ND23
VASSIQRGRDMGLPS	DUOX2	426	Q9NRD8
RRQAEQGGMAVTTPA	CCDC9B	91	Q6ZUT6
NVGRGSSMGLPRARQ	HMGXB3	526	Q12766
MQQGCDISPRSLSGR	GRIA2	606	P42262
MNTPRGGVGSVALVN	KLHL8	446	Q9P2G9
VSPAASRNGMSVAGN	PDZD2	2036	O15018
SRNGMSVAGNRQSEP	PDZD2	2041	O15018
NVGAPAAGMNAAVRS	PFKL	406	P17858
INVGAPAAGMNAAVR	PFKP	416	Q01813
PAAGMNAAVRSAVRV	PFKP	421	Q01813
ITGMCNNRRSPTLGA	MPO	176	P05164
RGMSAQGGAPSRQKA	NAV3	991	Q8IVL0
RPAANLVCLSGMNGS	FAM234B	181	A2RU67
GVPPASMRRAADQNG	DERL1	221	Q9BUN8
SVMDQGPAGNRTVNR	KIR2DS3	276	Q14952
GQRRMVAADSNVGPS	GLI2	1106	P10070
LVGRDQSSMQLRTPG	ATP9A	516	O75110
VVSLVNGRPGAMNFS	LAMA5	231	O15230
MARGVRGRAPSTGAQ	HCN3	581	Q9P1Z3
GSGPSFRSNQRKMLN	CDC25C	16	P30307
GQPSRASMVLLQSSG	NPHP4	591	O75161
SVMDQGPAGNRTVNR	KIR2DS5	276	Q14953
MAANPQGRISCTGRL	PALLD	1076	Q8WX93
MDVCLSSAQQPGRRG	METTL21C	1	Q5VZV1
SNDGTQPSKRRRMGS	PHF10	36	Q8WUB8
MGTSRRGLRGPAQVS	ARHGAP33	986	O14559
ANRGSSPQVMSRSNG	IGSF11	376	Q5DX21
SQMQGPRTRARLGAN	KLHL12	266	Q53G59
SVAPMNVRRGLAGAT	KLHL12	361	Q53G59
FINRNAAGTGRMSAP	CASC3	296	O15234
GSAADQMALRPGTQI	CARD14	601	Q9BXL6
MLQGPRALASAAGQT	E2F2	1	Q14209
PRSFMRLNDLSGAGG	CACNA1G	16	O43497
RGPQGAANPMDSSRS	C6orf141	11	Q5SZD1
PGARSHRGALMDSQQ	CHRDL1	226	Q9BU40
MTNPSRAGVILNRGF	CENPJ	21	Q9HC77
TANRPMGAGEALRRV	ILF3	261	Q12906
GRRPSDLTISINQMG	BCL9L	911	Q86UU0
PRGLAPNTRLNNGSM	CERKL	441	Q49MI3
MLSPQRVAAAASRGA	ATL3	1	Q6DD88
IASLPRNIGNAGMVA	IRAG2	376	Q12912
VQQGGNMSGLARRSP	KCNE1	21	P15382
MGASVSRGRAARVPA	FBXO27	1	Q8NI29
RSGARPRLASAEMQG	BCAM	71	P50895
PAGEPRGSQASFMQR	HCN2	151	Q9UL51
QGGNMSGLARRSPRS	KCNE1B	26	A0A087WTH5
SLRNRDMRGNPGQSL	OR1E3	291	Q8WZA6
RRASMQPIQIAEGTG	NUMA1	1966	Q14980
GSMALNARPQSPREG	PARD3	1106	Q8TEW0
NGGLFIMNGSRRRTP	PHAX	271	Q9H814
GMRNGPAQTRVSSSS	OTOG	51	Q6ZRI0
AQDPQGQGRVRTGMA	NUTM2F	556	A1L443
AQDPQGQGRVRTGMA	NUTM2G	541	Q5VZR2
SAAAVAGPEMQTGRN	EFEMP1	121	Q12805
MVGFGANRRAGRLPS	GOLM2	1	Q6P4E1
LRVQARAQPGTMSNG	SUSD2	481	Q9UGT4
MAAQRIRAANSNGLP	SH3BP4	1	Q9P0V3
SVRPGLAQSGMDQSR	SMARCD1	86	Q96GM5
GLSPSIPMASNSGRR	TADA2A	346	O75478
MEPGAGGRNTARAQR	BMT2	1	Q1RMZ1
RDARVMPGSGALQGQ	EPPK1	4571	P58107
SMIRASRNKNGPALG	MEX3C	301	Q5U5Q3
RIVQISGNSMPRGSG	SLTM	1006	Q9NWH9
VARLEQNGSPMGARG	SATB2	31	Q9UPW6
QSNPQLFALMGTRAG	SELENOO	511	Q9BVL4
VMTPQGRGTVAAAAA	SNRPB	141	P14678
RGSSMGVRNSPQALR	TAOK1	956	Q7L7X3
TMGGREQRQSPGAQR	STAG3L1	126	P0CL83
MAQLGGAANRAPTAS	SOWAHD	1	A6NJG2
TNRGSGGNIIAAMPN	SP1	216	P08047
QISPRSSTANFRGMG	POM121L2	711	Q96KW2
QASMPRERRDSGVGA	STARD8	471	Q92502
MEARAQSGNGSQPLL	SPRY2	1	O43597
LASVRGLQGRSMSVP	SHANK1	51	Q9Y566
LPRSSSMAAGLERNG	BAIAP2	361	Q9UQB8
GGAPLSATTQRFMNI	ACSL3	451	O95573
GSAAALRNLMANRPA	APC	721	P25054
ARGGSLAQPADRQQM	CLEC11A	206	Q9Y240
GQRGARAPAGMQVVS	CHPF2	136	Q9P2E5
GNITARDPAIMGLRN	C12orf4	441	Q9NQ89
NSGIRRNRSFPTMVG	TRAK1	911	Q9UPV9
SSRRPAAVGAGLQNM	USP17L3	71	A6NCW0
ASRAPRGSALGMSQR	USP43	1076	Q70EL4
NSLSGIAMNVPASRG	UBN2	1161	Q6ZU65
AGSQGPAMRDNRAVS	ZSCAN32	206	Q9NX65
SSRRPAAVGAGLQNM	USP17L4	71	A6NCW7
GQAPMRQRSATTTGS	RALGAPA1	726	Q6GYQ0
MAGSPSRAAGRRLQL	RHBG	1	Q9H310
NTLGTMGQSAPARLV	IGSF9B	401	Q9UPX0
TELPQAVAGRGNMRA	PPAN	251	Q9NQ55
GSMNRQGPESRLGRN	TRIM25	531	Q14258
RGRKRAAQQTPDMTG	ZNF521	381	Q96K83
SLGNMILRPGSDSRN	STAP1	196	Q9ULZ2
SSRRPAAVGAGLQNM	USP17L18	71	D6R9N7
ADLRARGQGSSPVAM	VCL	336	P18206
SSRRPAAVGAGLQNM	USP17L5	71	A8MUK1
SNRRPAAVGAGLQNM	USP17L21	71	D6R901
TMPVRGGTRLAQEAA	TNFRSF8	191	P28908
SSRRPAAVGAGLQNM	USP17L13	71	C9JLJ4
PAQLSSQAVNGMSRG	PXK	536	Q7Z7A4
QAMQRGLGRSEVSPG	SCART1	931	Q4G0T1
SSRRPAAVGAGLQNM	USP17L19	71	D6RCP7
MEQRGQNAPAASGAR	TNFRSF10B	1	O14763
SSRRPAAVGAGLQNM	USP17L1	71	Q7RTZ2
PQGMRISLQCQARGS	VSIG4	156	Q9Y279
LQCGQGSVPMGSRNR	TCF20	396	Q9UGU0
MLQKPRNRGRSGGQA	NSMCE3	1	Q96MG7
MPRVKAAQAGRQSSA	VRK1	1	Q99986
AILAARNGPVAMVGS	TIMM17A	101	Q99595
AKLASRAQGRAQMGP	ZC2HC1B	156	Q5TFG8
SNRRPAAVGAGLQNM	USP17L12	71	C9JPN9
SSRRPAAVGAGLQNM	USP17L24	71	Q0WX57
VAAQASASGMFPGQR	ZNF608	1496	Q9ULD9
SSRRPAAVGAGLQNM	USP17L8	71	P0C7I0
TARPNAFGMAQANRS	PHF8	991	Q9UPP1
RTRMQAQASIEGGPQ	SLC25A23	401	Q9BV35
SSRRPAAVGAGLQNM	USP17L6P	71	Q6QN14
NGRMRNNIKTGSSPN	ZEB2	341	O60315
SQPVVAAAGGRDGRM	VRTN	626	Q9H8Y1
SSRRPAAVGAGLQNM	USP17L22	71	D6RA61
GMAQEDSRRGQVPSS	ZNF652	21	Q9Y2D9
MSNRPNNNPGGSLRR	TRIP12	1	Q14669
NRNFQTTCGMSLPRG	ARHGAP21	596	Q5T5U3
SSRRPAAVGAGLQNM	USP17L15	71	C9J2P7
SSRRPAAVGAGLQNM	USP17L17	71	D6RBQ6
RARMQSLMGSQPAGS	TG	666	P01266
SREPGVSANRLMGGA	UHRF1BP1	341	Q6BDS2
VQPLSANMSQGGVSR	HIVEP1	601	P15822
NMAQRGIGVAASSVP	TFIP11	756	Q9UBB9
SSRRPAAVGAGLQNM	USP17L23	71	D6RBM5
SSRRPAAVGAGLQNM	USP17L2	71	Q6R6M4
MGDSRRRSLGNQPSS	THEG	1	Q9P2T0
SSRRPAAVGAGLQNM	USP17L20	71	D6RJB6
DAQRRPAQSVNRGGM	ALYREF	186	Q86V81
PAQSVNRGGMTRNRG	ALYREF	191	Q86V81
SSRRPAAVGAGLQNM	USP17L10	71	C9JJH3
SSRRPAAVGAGLQNM	USP17L11	71	C9JVI0
PLNGQMRLGLAAAAA	ZIC5	276	Q96T25